Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients

Daina B. Esposito, Linda Nelsen, Jennifer C.L. Hawes, Crystal N. Holick, Jennifer Maloney, Vinay Mehta, Daniel Mines, Gillian Pianka, Stephan F. Lanes
European Respiratory Journal 2014 44: P3472; DOI:
Daina B. Esposito
1Safety and Epidemiology, HealthCore, Inc., Andover, MA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Nelsen
2Center for Observational and Real World Evidence, Merck & Company, Inc., Whitehouse Station, NJ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer C.L. Hawes
1Safety and Epidemiology, HealthCore, Inc., Andover, MA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Crystal N. Holick
1Safety and Epidemiology, HealthCore, Inc., Andover, MA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Maloney
2Center for Observational and Real World Evidence, Merck & Company, Inc., Whitehouse Station, NJ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vinay Mehta
2Center for Observational and Real World Evidence, Merck & Company, Inc., Whitehouse Station, NJ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Mines
2Center for Observational and Real World Evidence, Merck & Company, Inc., Whitehouse Station, NJ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gillian Pianka
2Center for Observational and Real World Evidence, Merck & Company, Inc., Whitehouse Station, NJ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan F. Lanes
1Safety and Epidemiology, HealthCore, Inc., Andover, MA,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Background: Allergic rhinitis (AR) is the most common allergic disease. Allergen immunotherapy (AI) is the only available treatment that modifies the allergic process instead of suppressing symptoms. Whether AI or AR patients have an increased incident rate (IR) of autoimmune disorders is unknown.

Objectives: Compare IRs of autoimmune disorders in AI, AR, and non-AR patients.

Methods: This retrospective cohort study included members of the HealthCore Integrated Research DatabaseSM age ≥5 years (01Jan2004-30Sep2011). Cohorts included patients with neither AR nor AI, specialist-diagnosed AR patients unexposed to AI, and AI patients with AR. We calculated IR ratios (IRRs) and their 95% confidence intervals.

Results: The cohorts included 1,582,205 non-AR, 1,723,956 AR, and 109,157 AI patients.

View this table:
  • View inline
  • View popup

Age and gender-adjusted IRRs of select autoimmune disorders

Conclusions: Many autoimmune disorders are more commonly diagnosed in AR than non-AR patients.

  • Allergy
  • Epidemiology
  • Chronic disease
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
Daina B. Esposito, Linda Nelsen, Jennifer C.L. Hawes, Crystal N. Holick, Jennifer Maloney, Vinay Mehta, Daniel Mines, Gillian Pianka, Stephan F. Lanes
European Respiratory Journal Sep 2014, 44 (Suppl 58) P3472;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Autoimmune disorders in allergen immunotherapy, allergic rhinitis, and non-allergic patients
Daina B. Esposito, Linda Nelsen, Jennifer C.L. Hawes, Crystal N. Holick, Jennifer Maloney, Vinay Mehta, Daniel Mines, Gillian Pianka, Stephan F. Lanes
European Respiratory Journal Sep 2014, 44 (Suppl 58) P3472;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Effect of FESS on asthma patients with nasal polyposis and chronic sinusitis
  • Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
  • Seasonal influenza vaccine effectiveness in people with asthma: A systematic review
Show more 5.3 Allergy and Immunology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society